Acadian Asset Management LLC Axcella Health Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.41 - $2.77 $12,632 - $24,816	-8,959 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.58 - $2.82 $10,337 - $18,451	-6,543 Reduced 42.21%	8,959 $23,000
Q3 2021 Nov 12, 2021	SELL	$2.98 - $4.31 $93,828 - $135,704	-31,486 Reduced 67.01%	15,502 $45,000
Q2 2021 Aug 11, 2021	SELL	$3.08 - $5.13 $63,903 - $106,437	-20,748 Reduced 30.63%	46,988 $189,000
Q1 2021 May 11, 2021	SELL	$4.55 - $6.72 $73,923 - $109,179	-16,247 Reduced 19.35%	67,736 $322,000
Q4 2020 Feb 11, 2021	BUY	$4.24 - $5.97 $52,949 - $74,553	12,488 Added 17.47%	83,983 $436,000
Q3 2020 Nov 09, 2020	BUY	$4.12 - $5.91 $271,920 - $390,060	66,000 Added 1201.09%	71,495 $330,000
Q2 2020 Aug 12, 2020	BUY	$2.94 - $7.7 $16,155 - $42,311	5,495 New	5,495 $30,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.